ArticleCancer discovery2020

Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.

Kailong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.